Clinical trial
Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study
NCT02481206 is registered in ClinicalTrials.gov with Zoll Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study
- Lead sponsor
- Zoll Medical Corporation
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2015
- Completion date
- December 31, 2017
- Enrollment
- 66 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
sudden cardiac arrest, sudden cardiac death